Spaniard from Lidl-Trek - the winner of the 2025 Giro's stage 15 in Asiago - recalls his success and speaks on his hopes for ...

When Merck pulled off its $10 billion buyout of Verona, it was the only company that placed a bid on the British biotech, according to an SEC filing.

L'arcobaleno rosa apparso nei cieli del Veneto, l'esperto: «Vi spiego come un fenomeno ottico diventa uno spettacolo unico» ...

VERONA, Wis.- A new SSM Health campus is about to take shape on the south side of Verona, in hopes of expanding the city’s development and access to care.

VRNA stock has surged after Merck’s $10 billion merger acquisition. Here’s how you should play the stock.

Merck & Co. has struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive pulmonary disease treatment Ohtuvayre as it braces for the 2028 loss of ...

Merck is paying about $10 billion for Verona Pharma, expanding its respiratory disease drug portfolio.

Merck & Co. agreed to buy respiratory drugmaker Verona Pharma Plc for around $10 billion as part of its ongoing search for ways to fill the Keytruda-sized hole that will emerge over the next ...

Merck is closing in on a $10bn (€8.5bn) deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported. Picture: Pexels ...

VRNA jumps 20% after Merck unveils buyout to add COPD drug Ohtuvayre and reduce its reliance on Keytruda.

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.

Merck & Co. is closing in on an approximately $10 billion deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported.